|
WO2021020509A1
|
|
Composition for promoting growth or suppressing decrease of mesenchymal stem cells
|
|
WO2020145405A1
|
|
Three-dimensional dna structure interaction analysis method
|
|
WO2020071520A1
|
|
Peptide possessing mesenchymal-stem-cell mobilizing activity
|
|
WO2020071519A1
|
|
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
WO2020040293A1
|
|
Production method for mesenchymal stem cells
|
|
JP2020164484A
|
|
Mesenchymal stem cell or bone marrow cell proliferation promoting composition
|
|
US2021024594A1
|
|
Therapeutic Agent for Psoriasis
|
|
EP3718561A1
|
|
Therapeutic agent for inflammatory bowel disease
|
|
US2020291359A1
|
|
Ectodermal mesenchymal stem cells and method for producing same
|
|
CA3058877A1
|
|
Therapeutic medicine for fibrous disease
|
|
EP3556378A1
|
|
Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
|
